Pédiatrie Neuroblastomes
EUSA-PASS (EUSA-DB-0001)
A Post-Authorisation Safety Study Patient Registry of Patients With High-risk Neuroblastoma Being Treated With the Monoclonal Antibody Dinutuximab Beta
Paris
GUDRUN SCHLEIERMACHER